Navigation Links
Tissue Genesis Begins FDA-Approved Clinical Trial
Date:4/19/2011

HONOLULU, April 19, 2011 /PRNewswire/ -- Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital.  Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.  The clinical trial commenced enrollment in April and is led by Dr. Charles B. Ross, a board-certified vascular surgeon and Chief of the Division of Vascular Surgery and Endovascular Therapeutics at the University of Louisville Hospital.

Peripheral vascular disease affects over eight million people in the United States.  By 2020, the number is expected to increase by 43 percent.  PVD includes damage to or blockage in the blood vessels of the peripheral arteries and veins, causing pain and weakness.  Approximately 25 percent of patients progress to critical limb ischemia (CLI), oftentimes leading to amputation In the United States, 130,000 amputations are performed annually due to PVD.

Researchers have been actively seeking a way to coat the inside of synthetic grafts used to treat PVD so that they more closely resemble native vessels and increase long-term graft survival.  The stromal vascular fraction of adipose tissue contains millions of regenerative cells, which can be used to coat the inner surface of vascular grafts.  "Based on previous studies, the potential of ASCs to increase the patency and life of the graft is tremendous," states Dr. Stuart Williams, Chief Science Officer for Tissue Genesis and Executive and Scientific Director of the Cardiovascular Innovation Institute in Louisville, Kentucky.

ASCs are being increasingly looked to as a readily available source abundant in adult stem cells.  Compared to bone marrow de
'/>"/>

SOURCE Tissue Genesis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
2. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
3. Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers
4. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
5. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
6. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
7. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
8. Dont Wait - Do It Now!(TM) Become an Organ and Tissue Donor
9. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
10. AlloSource, Tissue Recipient Join Stars of Life Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)
11. Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Willow Grove, PA (PRWEB) August 28, 2014 ... talent, and create a culture that will allow individuals ... that are becoming increasingly important for employers looking to ... life science industries are embracing this trend, as the ... the fabric of a company, which will have real ...
(Date:8/28/2014)... 2014   SunTrust Robinson Humphrey (STRH) ... to its equity research team in biotechnology and ... in equity research demonstrates our commitment to providing ... enhance their investment decision making," said Biff ... continue to make significant investments in differentiated content ...
(Date:8/28/2014)... Calif. , Aug. 28, 2014  Armetheon, ... on developing novel mid- to late-stage cardiovascular drug ... million in its first round of financing. The ... Investments and Hercules Bioventures with participation from investors ... and pharmaceutical executive, Dr. Larry Hsu , ...
(Date:8/28/2014)... Washington, USA (PRWEB) August 27, 2014 ... next month for SPIE Laser Damage 2014 ... optical materials for high-power lasers will run 14-17 September. ... society for optics and photonics . , The premier ... for understanding laser damage to optical materials will engage ...
Breaking Biology Technology:Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3
... , NEW YORK, Sept. 9 ... Vice President and General Manager of Informatics at Thermo Fisher ... HUNT Research Center and Biobank, about data integration: the benefits ... life sciences companies. , , ...
... Mass., Sept. 9 EnVivo Pharmaceuticals today announced the appointment ... financial officer. DiPalma is responsible for overall financial operations ... , "EnVivo has grown to the point where ... our broad pipeline and increasing business opportunities," said Kees Been, ...
... , , PRINCETON, N.J., Sept. 9 ... clinical development services to innovative pharmaceutical, biotechnology, generic drug ... completely paid down its Convertible Senior Notes that were ... be used for general corporate purposes. , ...
Cached Biology Technology:Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains 2EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer 2PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion 2
(Date:8/29/2014)... the University of Texas Medical Branch at Galveston has gone ... can completely protect monkeys against a lethal dose of Ebola ... when the disease is severe. , Thomas Geisbert, professor of ... discussing advances in Ebola treatment research. The filoviruses known ... deadly of pathogens, with fatality rates of up to 90 ...
(Date:8/29/2014)... release is available in German . ... players in the natural nitrogen cycle on Earth and ... bacteria were thought to depend on nitrite as their ... by Holger Daims, a microbiologist at the University of ... hydrogen as an alternative source of energy. The oxidation ...
(Date:8/29/2014)... a cell,s nucleus, chromosomal DNA is tightly bound ... biologists call chromatin. Until about two decades ago, ... mere packing material around which the glamorous DNA ... a greater appreciation for how DNA/histone interactions govern ... research institutions studying the sequence of the genome ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3
... come in various shapes and sizes. Each cell is shaped ... specific function. When things go wrong and a cell does ... and the cell can cause problems in the body. Researchers ... for Atomic and Molecular Physics (AMOLF), The Netherlands, have now ...
... scientists were able to differentiate metastatic cancer cells from ... measures the softness of the cells. The study, ... of the journal Nature Nanotechnology, represents one of the ... cells from cancer patients and apply nanotechnology to analyze ...
... from a key molecular receptor that normally switches on ... in the presence of stress and toxins may help ... in premature newborns, according to scientists at the American ... J. Hackam and his laboratory team at the Childrens ...
Cached Biology News:How cells keep in shape 2Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 2Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 3Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 4Leading cause of death in 'preemies' might be controlled by resetting a molecular switch 2